This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,230.60 and a period of performance through April 29, 2025. The contract is a firm-fixed-price delivery order, which indicates that the pricing is pre-determined. The contract is not set aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,568.95 contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price, indefinite delivery vehicle with an ultimate completion date of April 14, 2025. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of REXULTI 2 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $3,928.00 and a completion date of September 27, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 1 MG TABLET 30S, a prescription medication, with a ceiling value of $2,655.96 and a period of performance through August 13, 2024. The contract was awarded on August 12, 2024 and is a firm fixed-price, delivery order contract with no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a prescription medication, with a ceiling value of $1,951.94 and a period of performance through April 28, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is for the delivery of REXULTI 2 mg tablets, a prescription medication. The contract has a ceiling value of $2,258.43 and a performance period ending on September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 0.5 MG TABLET 30S, a prescription medication. The award has a firm fixed price, a ceiling value of $6,103.11, and an ultimate completion date of June 5, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,135.20, is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This is a $11,265.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication REXULTI 1 MG TABLET 30S. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,995.23, is for the supply of REXULTI 0.5 MG TABLET 30S, a medication used in the treatment of various conditions. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price type. The contract is not designated as a set-aside. AmerisourceBergen holds a...